Drugs / GSK2944404
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01822639 | Apr → May 2013 | hypertensive disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2944404 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01822639 ↗ |
| Route | Oral | “for single dose oral administration in each period.” NCT01822639 ↗ |